Overactive Bladder - Results from #1920

Understanding the effects on HR-QoL of treatment for overactive bladder: A detailed analysis of EQ-5D clinical trial data for mirabegron - Abstract May 22, 2013

Overactive bladder symptom severity is associated with falls in community-dwelling adults: LOHAS study - Abstract May 21, 2013

Urethral dilatation: Is there any benefit over cystoscopy and distension? A randomized trial in women with overactive bladder symptoms - Abstract May 17, 2013

Botulinum toxin treatment for bladder dysfunction - Abstract May 16, 2013

Imidafenacin for the treatment of overactive bladder - Abstract May 16, 2013

AUA 2013 - Session Highlights: Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction - Annual Meeting at the AUA May 15, 2013

Prognostic factors of endoscopic treatment of vesicoureteral reflux in spinal cord injured patients - Abstract May 14, 2013

Botulinum toxin-What urologic uses does the data support? - Abstract May 10, 2013

New developments in the management of overactive bladder: Focus on mirabegron and onabotulinumtoxinA - Abstract May 9, 2013

Overactive bladder in the elderly - Abstract May 8, 2013

Clinical features of supervoiders who suffer from lower urinary tract symptoms: A propensity score-matching study - Abstract May 8, 2013

Auricular acupuncture in patients with detrusor overactivity : A pilot study - Abstract May 1, 2013

Short-term effects of a systematized bladder training program for idiopathic overactive bladder: A prospective study - Abstract April 30, 2013

OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: A randomised, double-blind, placebo-controlled trial - Abstract April 29, 2013

Understanding the dissemination of sacral neuromodulation - Abstract April 26, 2013

Onabotulinum toxin A (Botox®) in the treatment of neurogenic bladder overactivity - Abstract April 25, 2013

The utility of urodynamics in clinically suspected obstruction after anti-incontinence surgery in women - Abstract April 24, 2013

Estimating the cost-effectiveness of onabotulinumtoxinA for neurogenic detrusor overactivity in the United States - Abstract April 23, 2013

The assessment of a novel electrical stimulation waveform recently introduced for the treatment of overactive bladder - Abstract April 22, 2013

The therapeutic effects of repeated detrusor injections between 200 or 300 units of onabotulinumtoxinA in chronic spinal cord injured patients - Abstract April 22, 2013

Page 97 of 122